Aakanksha Agarwal

Aakanksha Agarwal

Auto-generated profile, based on publicly available information

Aakanksha Agarwal

Amity Institute of Click Chemistry Research and Studies Amity University, Uttar Pradesh, Sector-125, Noida, U.P-201313, India

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
AKAjay Kesharwani
Ajay Kesharwani
DKDr. Suja K.P
Dr. Suja K.P
RNReshmi Nair
Reshmi Nair
AAAakanksha Agarwal
Aakanksha Agarwal
NMNripendra Nath Mishra
Nripendra Nath Mishra
SGSatish Kumar Gupta
Satish Kumar Gupta
Development of new and effective therapeutics for sexually transmitted herpes simplex virus-2 (HSV-2) infection is important from public health perspective. With an aim to identify natural products from medicinal plants, in the present study, the potential of Terminalia chebula Retz was investigated for its activity against HSV-2. Fruits of Terminalia chebula Retz were used to prepare 50% ethanolic extract. In addition, chebulagic acid and chebulinic acid both purified from T. chebula were also used. The extract as well as purified compounds were first used to determine their in vitro cytotoxicity on Vero cells by MTT assay. T. chebula extract, chebulagic acid, chebulinic acid along with acyclovir were subsequently assessed for direct anti-viral activity, and their ability to inhibit attachment and penetration of HSV-2 to the Vero cells. In addition, their anti-HSV-2 activity was also determined by in vitro post-infection plaque reduction assay. Cytotoxicity assay using Vero cells revealed CC50 = 409.71 ± 47.70 μg/ml for the extract whereas chebulagic acid and chebulinic acid showed more than 95% cell viability up to 200 μg/ml. The extract from T. chebula (IC50 = 0.01 ± 0.0002 μg/ml), chebulagic (IC50 = 1.41 ± 0.51 μg/ml) and chebulinic acids (IC50 = 0.06 ± 0.002 μg/ml) showed dose dependent potent in vitro direct anti-viral activity against HSV-2. These also effectively prevented the attachment as well as penetration of the HSV-2 to Vero cells. In comparison, acyclovir showed poor direct anti-viral activity and failed to significantly (p > 0.05) prevent the attachment as well as penetration of HSV-2 to Vero cells when tested upto 50 μg/ml. However, in post-infection plaque reduction assay, T. chebula extract, chebulagic and chebulinic acids showed IC50 values of 50.06 ± 6.12, 31.84 ± 2.64, and 8.69 ± 2.09 μg/ml, respectively, which were much lower than acyclovir (71.80 ± 19.95 ng/ml). The results presented herein suggest that T. chebula extract, chebulagic and chebulinic acids have higher direct antiviral activity against HSV-2 and efficacy to inhibit virus attachment and penetration to the host cells as compared to acyclovir. However, acyclovir is more potent to inhibit post-infection virus replication. Hence, T. chebula may be a useful candidate for developing alternative therapy for prevention of sexually transmitted HSV-2 infection. ᅟ

11 August 2022 in ACS Omega
Verified
Journal Article
Open access
MMMisba Majood
Misba Majood
PGPiyush Garg
Piyush Garg
RCRadhika Chaurasia
Radhika Chaurasia
AAAakanksha Agarwal
Aakanksha Agarwal
SMSujata Mohanty
Sujata Mohanty
MMMonalisa Mukherjee
Monalisa Mukherjee
Nanotechnology advancements and applications have paved the way for new possibilities in regenerative medicine and tissue engineering. It is a relatively new field that has the potential to improve stem cell differentiation and therapy greatly. Numerous studies have demonstrated that nanomaterials can function as a physiological niche for the formation and differentiation of stem cells. However, quantum dots (QDs), such as carbon quantum dots (CQDs) and graphene quantum dots (GQDs), have shown considerable promise in the field of regenerative medicine. To date, most research has focused on stem cell tracking and imaging using CQDs. However, their interaction with stem cells and the associated possibility for differentiation by selectively focusing chemical signals to a particular lineage has received scant attention. In this mini-review, we attempt to categorize a few pathways linked with the role of CQDs in stem cell differentiation.

17 June 2022 in ACS Omega
Verified
Journal Article
Open access
AAAakanksha Agarwal
Aakanksha Agarwal
SJSampathkumar Jeevanandham
Sampathkumar Jeevanandham
SSSujata Sangam
Sujata Sangam
ACArnab Chakraborty
Arnab Chakraborty
MMMonalisa Mukherjee
Monalisa Mukherjee
An enchanting yet challenging task is the development of higher productivity in plants to meet the ample food demands for the growing global population while harmonizing the ecosystem using front-line technologies. This has kindled the practice of green microalgae cultivation as a driver of key biostimulant products, targeting agronomic needs. To this end, a prodigious and economical strategy for producing bioactive compounds (sources of secondary metabolites) from microalgae using carbon-based nanomaterials (CNMs) as a platform can circumvent these hurdles. Recently, the nanobionics approach of incorporating CNMs with living systems has emerged as a promising technique to develop organelles with new and augmented functions. Herein, we discuss the importance of 2D carbon nanosheets (CNS) as an alternative carbon source for the phototrophic cultivation of microalgae. CNS not only aids in cost reduction for algal cultivation but also confers combinatorial innate or exogenous functions that enhance its programmed biosynthetic metabolism, proliferation, or tolerance to stress. Moreover, the inherent ability of CNS to act as efficient biocatalysts can enhance the rate of photosynthesis. The primary focus of this mini-review is the development of an economic route for enhanced yield of bioactive compounds while simultaneously serving as a heterogeneous platform for enhancing the sustainable production of biostimulants including bioactive compounds from algal biomass for pharmaceutical and nutraceutical applications.

3 March 2022 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
SSSujata Sangam
Sujata Sangam
SJSimran Jindal
Simran Jindal
AAAakanksha Agarwal
Aakanksha Agarwal
BBBasu Dev Banerjee
Basu Dev Banerjee
PPPuja Prasad
Puja Prasad
MMMonalisa Mukherjee
Monalisa Mukherjee
Engineered well-ordered hybrid nanomaterials are symbolically at a pivotal point, just ahead of the long-anticipated transformation of the human race. Incorporating newer carbon nanomaterials like graphene quantum dots (GQDs) with tetrapyrrolic porphyrins (Pp) and phthalocyanines (Pc) is crucial for achieving exquisite molecular nanoarchitectures that are superior to their individual components. The outcomes of this, particularly in the case of graphene quantum dot-porphyrin/phthalocyanine (GQD-Pp/Pc) hybrids, remain comprehensively unexplored to date. Interestingly, GQD-Pp/Pc hybrids provide a modern strategy to regulate matter by utilising intramolecular and organisational properties to create well-defined nanocomposites via a synergistic enhancement effect. The high molar absorption coefficient and enhanced energy transfer, hole and electron transfer abilities capabilities allow Pp and Pc to exhibit a wide spectrum of photophysical and photochemical features. However, their low biostability, non-specific tumor-targeting properties, hydrophobicity, and low cellular internalisation efficiency limit their extensive biomedical utility. Conjugating Pp/Pc to nanocarriers such as GQDs improves their targeted delivery, immunological tolerance, and longevity. Due to the zero-order release kinetics of GQDs, they can assist in maintaining a steady rate of photosensitiser (PS) delivery at the desired site. To completely rationalise the functionalization of GQD-Pp/Pc species at interfaces, we investigate the current prominence and future potential of porphyrin-related graphene nanosystems, especially GQDs, for the development of various applications. This encouraging report demonstrates how GQD-Pp/Pc species can be used to examine new phenomena at the multidisciplinary level. Notably, a customised hybrid system optimises amendable and diverse functional properties, yielding a ray of hope in the fields of photodynamic therapy (PDT), photocatalysis, solar cells, sensing, and beyond via various photo-physicochemical approaches such as electron transfer, catalytic transformation, light-harvesting, and axial/peripheral ligation of adducts. Gratifyingly, the covalent and non-covalent coupling of functional molecular units at interfaces enable new properties to be generated in hybrid systems.

6 July 2022 in ACS Applied Polymer Materials
Verified
Journal Article
Closed access
AAAakanksha Agarwal
Aakanksha Agarwal
AKArun Kumar
Arun Kumar
PGPiyush Garg
Piyush Garg
ACArnab Chakraborty
Arnab Chakraborty
RVRanjan Verma
Ranjan Verma
MMMonalisa Mukherjee
Monalisa Mukherjee

24 October 2018 in Viruses
Verified
Journal Article
Open access
PDF file
NMNripendra Nath Mishra
Nripendra Nath Mishra
AKAjay Kesharwani
Ajay Kesharwani
AAAakanksha Agarwal
Aakanksha Agarwal
DKDr. Suja K.P
Dr. Suja K.P
RNReshmi Nair
Reshmi Nair
SGSatish Kumar Gupta
Satish Kumar Gupta
Herpes simplex virus-2 (HSV-2) infection is the most common cause of genital ulcers. The impact of ulcers also demonstrates a strong link to the human immunodeficiency virus (HIV) infection. Complications, drug resistance, and side-effects of anti-viral drugs make the treatment of HSV-2 infection challenging. Herbal medicines have shown potential against HSV-2 and HIV infections. In this context, polyherbal gel formulation comprising 50% ethanolic extracts from Acacia catechu, Lagerstroemia speciosa, Terminalia chebula and Phyllanthus emblica has been developed. The gel formulation significantly exhibited virucidal activity against both HIV-1 and HSV-2 infections with IC50, 55.93 ± 5.30 µg/mL and 27.26 ± 4.87 µg/mL, respectively. It also inhibited HSV-2 attachment and penetration to the Vero cells with an IC50 = 46.55 ± 1.25 µg/mL and 54.94 ± 2.52 µg/mL respectively, which were significantly lower than acyclovir. However, acyclovir is more potent in post-infection assay with an IC50 = 0.065 ± 0.01 µg/mL whereas gel formulation showed an IC50 = 469.05 ± 16.65 µg/mL under similar conditions. Gel formulation showed no inhibitory effect on the viability of lactobacilli, human vaginal keratinocyte cells (Vk2/E6E7), and the integrity of the Caco-2 cells monolayer. Gel formulation did not lead to any significant increase in the secretion of pro-inflammatory cytokines and mutagenic index. The proposed gel formulation may be a promising candidate microbicide for the prevention of sexually transmitted HIV-1 and HSV-2.